Aardvark Therapeutics, Inc. (AARD)
NASDAQ · Healthcare
Aardvark Therapeutics, Inc. Operating Income 2024–2025
Aardvark Therapeutics, Inc. annual/quarterly operating income history and growth rate from 2024 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Aardvark Therapeutics, Inc. operating income for the quarter ending March 31, 2026 was -22.5 M, a 114.56% increase year-over-year.
- Aardvark Therapeutics, Inc. operating income for the twelve months ending March 31, 2026 was -66.5 M.
- Aardvark Therapeutics, Inc. annual operating income for 2025 was -62.7 M, a 175.29% increase from 2024.
- Aardvark Therapeutics, Inc. annual operating income for 2024 was -22.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aardvark Therapeutics, Inc. Operating Income — FAQ
Aardvark Therapeutics, Inc. (AARD) operating income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Aardvark Therapeutics, Inc.'s operating income?
Aardvark Therapeutics, Inc. (AARD) reported operating income of -$63M for fiscal 2025.
Where can I see AARD's operating income history?
The chart and table above show Aardvark Therapeutics, Inc.'s operating income by year and by quarter, including the growth rate.